Peter Shaw

6.1k citations

117 papers · 3.3k indexed · 1 hit paper · h-index 27

Impact in

Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
Cancer Research top 5%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation

Papers in ⓘ

Molecular Biology 30
Pharmacology 25
- Pharmacogenetics and Drug Metabolism 24

Co-authors: Fei Huang (5 shared papers)Faizan Niazi (8 shared papers)Xia Han (3 shared papers)Tsutomu Shimada (2 shared papers)Hiroshi Yamazaki (2 shared papers)F. Peter Guengerich (2 shared papers)Mathew Nicholls (5 shared papers)Roy D. Altman (2 shared papers)
Journals: Pharmacogenomics (5 papers)Archives of Biochemistry and Biophysics (3 papers)Clinical Pharmacology & Therapeutics (3 papers)Oral Oncology (3 papers)Genes (3 papers)
Partner nations: United States China Australia

In The Last Decade

Peter Shaw

111 papers receiving 3.3k citations

Hit Papers

align trajectories log scale

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts 2005 · 613 citations

Peers

Countries citing papers authored by Peter Shaw

Since Specialization

Citations

This map shows the geographic impact of Peter Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Shaw more than expected).

Fields of papers citing papers by Peter Shaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Shaw. The network helps show where Peter Shaw may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Shaw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Shaw Line = papers co-authored together Peter Shaw links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts Breast Cancer Research ·Yudi Pawitan, Judith Bjöhle, Lukas C. Amler, Anna-Lena Borg, Suzanne Egyházi, Per Hall, Xia Han, Lars Holmberg, Fei Huang, Sigrid Klaar, Edison T. Liu, Lance D. Miller, Hans Nordgren, Alexander Ploner, Kerstin Sandelin, Peter Shaw, Johanna Smeds, Lambert Skoog, Sara Wedrén, Jonas Bergh Hit paper breakdown →	2005	613
2	Identification of Candidate Molecular Markers Predicting Sensitivity in Solid Tumors to Dasatinib: Rationale for Patient Selection Cancer Research ·Fei Huang, Karen A. Reeves, Xia Han, Craig Fairchild, Suso Platero, Tai W. Wong, Francis Lee, Peter Shaw, Edwin Clark	2007	274
3	EMT is the dominant program in human colon cancer BMC Medical Genomics ·Andre Loboda, Michael Nebozhyn, James Watters, Carolyne A Buser, Peter Shaw, Pearl S. Huang, Laura van’t Veer, Rob A.�E.�M. Tollenaar, David Jackson, Deepak Agrawal, Hongyue Dai, Timothy J. Yeatman	2011	233
4	Roles of Cytochromes P450 1A2 and 3A4 in the Oxidation of Estradiol and Estrone in Human Liver Microsomes Chemical Research in Toxicology ·Hiroshi Yamazaki, Peter Shaw, F. Peter Guengerich, Tsutomu Shimada	1998	167
5	DLK1-DIO3 Genomic Imprinted MicroRNA Cluster at 14q32.2 Defines a Stemlike Subtype of Hepatocellular Carcinoma Associated with Poor Survival Journal of Biological Chemistry ·John M. Luk, Julja Burchard, Chunsheng Zhang, Angela M. Liu, Kwong F. Wong, Felix H. Shek, Nikki P. Lee, Sheung Tat Fan, Ronnie T. P. Poon, Irena L. Ivanovska, Ulrike Philippar, Michele A. Cleary, Carolyn A. Buser, Peter Shaw, Chuen Neng Lee, Daniel G. Tenen, Hongyue Dai, Mao Mao	2011	126
6	Anti-Inflammatory Effects of Intra-Articular Hyaluronic Acid: A Systematic Review Cartilage ·Roy D. Altman, Asheesh Bedi, Ajay Manjoo, Faizan Niazi, Peter Shaw, Philip J. Mease	2018	124
7	Different Contributions of Cytochrome P450 2C19 and 3A4 in the Oxidation of Omeprazole by Human Liver Microsomes: Effects of Contents of These Two Forms in Individual Human Samples Journal of Pharmacology and Experimental Therapeutics ·Hiroshi Yamazaki, Kiyoshi Inoue, Peter Shaw, W J Checovich, F. Peter Guengerich, Tsutomu Shimada	1997	120
8	Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity Molecular Cancer ·Ayan Banerjea, Shafi Ahmed, Rebecca Hands, Fei Huang, Xia Han, Peter Shaw, Roger Feakins, Stephen A. Bustin, Sina Dorudi	2004	116
9	Efficacy and safety of repeated courses of hyaluronic acid injections for knee osteoarthritis: A systematic review Seminars in Arthritis and Rheumatism ·Roy D. Altman, Josh Hackel, Faizan Niazi, Peter Shaw, Mathew Nicholls	2018	101
10	Reconstitution Premixes for Assays Using Purified Recombinant Human Cytochrome P450, NADPH-Cytochrome P450 Reductase, and Cytochromeb5 Archives of Biochemistry and Biophysics ·Peter Shaw, Natilie Hosea, David V. Thompson, Janean M. Lenius, F. Peter Guengerich	1997	80
11	Studies on the maintenance of cytochromes P‐450 and b₅, monooxygenases and cytochrome reductases in primary cultures of rat hepatocytes FEBS Letters ·M.H. Grant, Maureen A. L. Melvin, Peter Shaw, William T. Melvin, M.D. Burke	1985	71
12	The efficacy of multiple versus single hyaluronic acid injections: a systematic review and meta-analysis BMC Musculoskeletal Disorders ·Andrew L. Concoff, Parag Sancheti, Faizan Niazi, Peter Shaw, Jeffrey Rosen	2017	64
13	Evaluation of the Paraoxonases as Candidate Genes for Stroke Stroke ·Koustubh Ranade, Todd G. Kirchgessner, Olga A. Iakoubova, James J. Devlin, Terrye Delmonte, Priya Vishnupad, Lester Hui, Zenta Tsuchihashi, Frank M. Sacks, Marc S. Sabatine, Eugene Braunwald, Thomas J. White, Peter Shaw, Nicholas C. Dracopoli	2005	62
14	Quantifying factors for the success of stratified medicine Nature Reviews Drug Discovery ·Mark Trusheim, Breon Burgess, Sean X. Hu, Theresa Long, Steven D. Averbuch, Aiden Flynn, A Lieftucht, Abhijit Mazumder, Judy Milloy, Peter Shaw, David J. Swank, Jian Wang, Ernst R. Berndt, Federico Goodsaid, Michael Palmer	2011	60
15	The human dioxin‐inducible NAD(P)H:quinone oxidoreductase cDNA‐encoded protein expressed in COS‐1 cells is identical to diaphorase 4 European Journal of Biochemistry ·Peter Shaw, Allison B. Reiss, Milton Adesnik, Daniel W. Nebert, Josephine Schembri, Anil K. Jaiswal	1991	52
16	Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study BMC Medicine ·Per Hall, Alexander Ploner, Judith Bjöhle, Fei Huang, Chin‐Yo Lin, Edison T. Liu, Lance D. Miller, Hans Nordgren, Yudi Pawitan, Peter Shaw, Lambert Skoog, Johanna Smeds, Sara Wedrén, John Öhd, Jonas Bergh	2006	51
17	Transcriptional regulation of the CYP2B1 and CYP2B2 genes by C/EBP-related proteins Biochemical Pharmacology ·Phuong-Van T. Luc, Milton Adesnik, Sabya Ganguly, Peter Shaw	1996	46
18	Purification and characterization of an anticonvulsant-induced human cytochrome P-450 catalysing cyclosporin metabolism Biochemical Journal ·Peter Shaw, Tristan S. Barnes, Don Cameron, J Engeset, William T. Melvin, G Omar, J C Petrie, W. R. Rush, Carolyn P. Snyder, P. H. Whiting, C. Roland Wolf, M.D. Burke	1989	46
19	A Comparison Between Rheological Properties of Intra-articular Hyaluronic Acid Preparations and Reported Human Synovial Fluid Advances in Therapy ·Mathew Nicholls, Ajay Manjoo, Peter Shaw, Faizan Niazi, Jeffrey Rosen	2018	45
20	[50] ANTIVIRAL ACTIVITY OF THE NON-NUCLEOSIDE POLYMERASE INHIBITOR, HCV-796, IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2b IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV Journal of Hepatology ·Stephen Villano, Donald G. Raible, D.S. Harper, John Speth, Partha K. Chandra, Peter Shaw, Geraldine Bichier	2007	44

About Peter Shaw

Peter Shaw is a scholar working on Molecular Biology, Pharmacology, Cancer Research, Oncology and Artificial Intelligence, having authored 117 papers that have together received 3.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (24 papers), Osteoarthritis Treatment and Mechanisms (8 papers), Drug Transport and Resistance Mechanisms (7 papers), Topic Modeling (7 papers), MicroRNA in disease regulation (7 papers), Natural Language Processing Techniques (6 papers), Advanced Graph Theory Research (6 papers) and Cancer-related molecular mechanisms research (6 papers). The work is most often cited by research in Pharmacology (582 citations), Cancer Research (581 citations), Oncology (935 citations), Rheumatology (306 citations) and Molecular Biology (1.3k citations). Peter Shaw has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Fei Huang, Faizan Niazi, Xia Han, Tsutomu Shimada, Hiroshi Yamazaki, F. Peter Guengerich, Mathew Nicholls, Roy D. Altman, Milton Adesnik and Yudi Pawitan. Their work appears in journals such as Pharmacogenomics, Archives of Biochemistry and Biophysics, Clinical Pharmacology & Therapeutics, Oral Oncology and Genes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact